![Frontiers | Lung Cancer Stem Cell Markers as Therapeutic Targets: An Update on Signaling Pathways and Therapies Frontiers | Lung Cancer Stem Cell Markers as Therapeutic Targets: An Update on Signaling Pathways and Therapies](https://www.frontiersin.org/files/Articles/873994/fonc-12-873994-HTML/image_m/fonc-12-873994-g001.jpg)
Frontiers | Lung Cancer Stem Cell Markers as Therapeutic Targets: An Update on Signaling Pathways and Therapies
![p63 expression in human tumors and normal tissues: a tissue microarray study on 10,200 tumors | Biomarker Research | Full Text p63 expression in human tumors and normal tissues: a tissue microarray study on 10,200 tumors | Biomarker Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40364-021-00260-5/MediaObjects/40364_2021_260_Fig2_HTML.png)
p63 expression in human tumors and normal tissues: a tissue microarray study on 10,200 tumors | Biomarker Research | Full Text
![TTF-1 and p63 for distinguishing pulmonary small-cell carcinoma from poorly differentiated squamous cell carcinoma in previously pap-stained cytologic material | Modern Pathology TTF-1 and p63 for distinguishing pulmonary small-cell carcinoma from poorly differentiated squamous cell carcinoma in previously pap-stained cytologic material | Modern Pathology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fmodpathol.3800629/MediaObjects/41379_2006_Article_BF3800629_Fig2_HTML.jpg)
TTF-1 and p63 for distinguishing pulmonary small-cell carcinoma from poorly differentiated squamous cell carcinoma in previously pap-stained cytologic material | Modern Pathology
![p63 expression in human tumors and normal tissues: a tissue microarray study on 10,200 tumors | Biomarker Research | Full Text p63 expression in human tumors and normal tissues: a tissue microarray study on 10,200 tumors | Biomarker Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40364-021-00260-5/MediaObjects/40364_2021_260_Fig1_HTML.png)
p63 expression in human tumors and normal tissues: a tissue microarray study on 10,200 tumors | Biomarker Research | Full Text
![p63 (Squamous, Basal & Myoepithelial Cell Marker) Ultraspecific Antibody Tested against >20,000 Human Proteins – enQuire BioReagents p63 (Squamous, Basal & Myoepithelial Cell Marker) Ultraspecific Antibody Tested against >20,000 Human Proteins – enQuire BioReagents](https://enquirebio.com/wp-content/uploads/2018/06/enQuire-Bio-8626-MSM8-P0-anti-p63-Squamous-Basal-Myoepithelial-Cell-Marker-antibody.jpeg)
p63 (Squamous, Basal & Myoepithelial Cell Marker) Ultraspecific Antibody Tested against >20,000 Human Proteins – enQuire BioReagents
![Effects of siRNA Silencing of TUG1 and LCAL6 Long Non-coding RNAs on Patient-derived Xenograft of Non–small Cell Lung Cancer | Anticancer Research Effects of siRNA Silencing of TUG1 and LCAL6 Long Non-coding RNAs on Patient-derived Xenograft of Non–small Cell Lung Cancer | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/38/1/179/F1.large.jpg)
Effects of siRNA Silencing of TUG1 and LCAL6 Long Non-coding RNAs on Patient-derived Xenograft of Non–small Cell Lung Cancer | Anticancer Research
![Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy - ScienceDirect Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1044579X17300974-gr2.jpg)
Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy - ScienceDirect
![Expression of P40 and P63 in lung cancers using fine needle aspiration cases. Understanding clinical pitfalls and limitations. - Abstract - Europe PMC Expression of P40 and P63 in lung cancers using fine needle aspiration cases. Understanding clinical pitfalls and limitations. - Abstract - Europe PMC](https://europepmc.org/articles/PMC5044754/bin/nihms783141f1a.jpg)
Expression of P40 and P63 in lung cancers using fine needle aspiration cases. Understanding clinical pitfalls and limitations. - Abstract - Europe PMC
![p63 IHC analysis with 4A4 antibody in lung tumorigenesis. A , bronchial... | Download Scientific Diagram p63 IHC analysis with 4A4 antibody in lung tumorigenesis. A , bronchial... | Download Scientific Diagram](https://www.researchgate.net/publication/9012549/figure/fig3/AS:280591447674880@1443909622094/p63-IHC-analysis-with-4A4-antibody-in-lung-tumorigenesis-A-bronchial-epithelium.png)
p63 IHC analysis with 4A4 antibody in lung tumorigenesis. A , bronchial... | Download Scientific Diagram
![TTF-1 and p63 for distinguishing pulmonary small-cell carcinoma from poorly differentiated squamous cell carcinoma in previously pap-stained cytologic material | Modern Pathology TTF-1 and p63 for distinguishing pulmonary small-cell carcinoma from poorly differentiated squamous cell carcinoma in previously pap-stained cytologic material | Modern Pathology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fmodpathol.3800629/MediaObjects/41379_2006_Article_BF3800629_Fig1_HTML.jpg)
TTF-1 and p63 for distinguishing pulmonary small-cell carcinoma from poorly differentiated squamous cell carcinoma in previously pap-stained cytologic material | Modern Pathology
![A panel of four immunohistochemical markers (CK7, CK20, TTF-1, and p63) allows accurate diagnosis of primary and metastatic lung carcinoma on biopsy specimens | SpringerLink A panel of four immunohistochemical markers (CK7, CK20, TTF-1, and p63) allows accurate diagnosis of primary and metastatic lung carcinoma on biopsy specimens | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00428-013-1488-z/MediaObjects/428_2013_1488_Fig1_HTML.gif)
A panel of four immunohistochemical markers (CK7, CK20, TTF-1, and p63) allows accurate diagnosis of primary and metastatic lung carcinoma on biopsy specimens | SpringerLink
![Subtyping Non–Small Cell Lung Cancer: Relevant Issues and Operative Recommendations for the Best Pathology Practice - Giulio Rossi, Giuseppe Pelosi, Mattia Barbareschi, Paolo Graziano, Alberto Cavazza, Mauro Papotti, 2013 Subtyping Non–Small Cell Lung Cancer: Relevant Issues and Operative Recommendations for the Best Pathology Practice - Giulio Rossi, Giuseppe Pelosi, Mattia Barbareschi, Paolo Graziano, Alberto Cavazza, Mauro Papotti, 2013](https://journals.sagepub.com/cms/10.1177/1066896913489346/asset/images/large/10.1177_1066896913489346-fig2.jpeg)
Subtyping Non–Small Cell Lung Cancer: Relevant Issues and Operative Recommendations for the Best Pathology Practice - Giulio Rossi, Giuseppe Pelosi, Mattia Barbareschi, Paolo Graziano, Alberto Cavazza, Mauro Papotti, 2013
The Use of P63 Immunohistochemistry for the Identification of Squamous Cell Carcinoma of the Lung | PLOS ONE
The Use of P63 Immunohistochemistry for the Identification of Squamous Cell Carcinoma of the Lung | PLOS ONE
![Lung cancer biopsy: Can diagnosis be changed after immunohistochemistry when the H&E-Based morphology corresponds to a specific tumor subtype? - ScienceDirect Lung cancer biopsy: Can diagnosis be changed after immunohistochemistry when the H&E-Based morphology corresponds to a specific tumor subtype? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1807593222005683-gr2.jpg)
Lung cancer biopsy: Can diagnosis be changed after immunohistochemistry when the H&E-Based morphology corresponds to a specific tumor subtype? - ScienceDirect
![A combination of cytokeratin 5/6, p63, p40 and MUC5AC are useful for distinguishing squamous cell carcinoma from adenocarcinoma of the cervix | Diagnostic Pathology | Full Text A combination of cytokeratin 5/6, p63, p40 and MUC5AC are useful for distinguishing squamous cell carcinoma from adenocarcinoma of the cervix | Diagnostic Pathology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13000-020-01018-7/MediaObjects/13000_2020_1018_Fig1_HTML.png)